JPRN-UMIN000005678
Completed
未知
Clinical trial of hepatic arterial infusion chemotherapy with multidrug resistance-associated protein 3-derived peptide for hepatocellular carcinoma - Hepatic arterial infusion chemotherapy with MRP3-derived peptide for hepatocellular carcinoma
Department of Gastroenterology, Kanazawa University Hospital0 sites12 target enrollmentJune 1, 2011
ConditionsHepatocellular carcinoma (HCC)
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Hepatocellular carcinoma (HCC)
- Sponsor
- Department of Gastroenterology, Kanazawa University Hospital
- Enrollment
- 12
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Severe complications associated with heart, kidney, lung, blood and coagulability 2\)Infection of HIV 3\)Past medical history of malignancy 4\)Surgical treatment, chemotherapy and radiation therrapy within 4 weeks 5\)Past medical history of Immunodeficiency, splenectomy and radiation of spleen 6\)medical treatments with steroid 7\)Patients who are during lactation 8\)Patients who are during pregnancy and expected pregnancy 9\)Past history of organ transplantation 10\)Patients who are predicted a difficulty of following clinical course 11\)Patients who are judged inappropriate for clinical trial
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Pilot study of hepatic arterial infusion chemotherapy followed by sorafenib for advanced hepatocellular carcinomaadvanced hepatocellular carcinomaJPRN-UMIN000009094Department of Gastroenterology and Metabolism,Hiroshima University Hospital55
Completed
Phase 1
A phase 1 trial of hepatic arterial infusion chemotherapy with high dose cisplatin and 5-fluorouracil for unresectable advanced and recurrent hepatocellular carcinomaJPRN-UMIN000015101Keio University, School of medicine, Department of Surgery18
Completed
Phase 1
A phase I,II trial of hepatic arterial infusion chemotherapy with cisplatin and 5-fluorouracil for unresectable advanced hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000013734Sapporo Medical University School of Medicine28
Completed
Phase 2
A phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosisJPRN-UMIN000000488Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital25
Completed
Phase 2
pilot study of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma patients in Child-Pugh score 8,9advanced hepatocellular carcinomaJPRN-UMIN000009272Department of Gastroenterology and Metabolism,Hiroshima University Hospital30